MAPT and Alzheimer disease: If it could be shown that neuromodulation via noninvasive brain stimulation could actually move an AD biomarker of pathologic Aβ, tau, or neuronal status in a positive direction, this would be a major step forward in developing disease-modifying treatments for AD.